3933 Stock Overview
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
The United Laboratories International Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$9.85 |
| 52 Week High | HK$11.74 |
| 52 Week Low | HK$6.52 |
| Beta | 0.058 |
| 11 Month Change | -10.78% |
| 3 Month Change | 16.84% |
| 1 Year Change | 22.21% |
| 33 Year Change | 86.55% |
| 5 Year Change | 105.21% |
| Change since IPO | 130.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3933 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -3.2% | 1.1% | 1.6% |
| 1Y | 22.2% | -9.4% | 10.1% |
Return vs Industry: 3933 exceeded the Hong Kong Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 3933 exceeded the Hong Kong Market which returned 10.1% over the past year.
Price Volatility
| 3933 volatility | |
|---|---|
| 3933 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 3933 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 3933's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 15,000 | n/a | www.tul.com.cn |
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules.
The United Laboratories International Holdings Limited Fundamentals Summary
| 3933 fundamental statistics | |
|---|---|
| Market cap | HK$17.90b |
| Earnings (TTM) | HK$3.12b |
| Revenue (TTM) | HK$15.05b |
5.7x
P/E Ratio1.2x
P/S RatioIs 3933 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3933 income statement (TTM) | |
|---|---|
| Revenue | CN¥14.01b |
| Cost of Revenue | CN¥7.54b |
| Gross Profit | CN¥6.47b |
| Other Expenses | CN¥3.56b |
| Earnings | CN¥2.91b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.60 |
| Gross Margin | 46.15% |
| Net Profit Margin | 20.76% |
| Debt/Equity Ratio | 18.0% |
How did 3933 perform over the long term?
See historical performance and comparison